Buy (150 RUB)
|Generate QR code
Open Access
Subscription or Fee Access
Clinical observation of patient with moya-moya syndrome complicated by transient ischemic attack followed by development of hemorrhagic stroke. Features of diagnosis and treatment
O. I. Tsibirova,
M. A. Privalova,
M. G. Sokolova,
A. Yu. Ulitin,
S. А. Privalova,
A. A. Tsibirov,
M. Ya. Belikova https://doi.org/10.33667/2078-5631-2023-21-54-60
Abstract
Moya-moya syndrome is a chronic cerebrovascular disease associated with narrowing of the arteries of the brain, manifested by headache, epileptic seizures, transient ischemic attack, leading to the development of ischemic or hemorrhagic stroke. To date, the main pathogenetic mechanisms of moya-moya syndrome have not yet been fully identified, but some studies have shown that an important component of the development of moya-moya is a genetic factor. However, if the issue of diagnosis of this syndrome can be considered solved – it is the use of neuroimaging methods (MRI, CT) with contrast of cerebral vessels, then the issue of treatment remains relevant. The article presents a clinical case of a patient with moya-moya syndrome with the transformation of an ischemic stroke into a hemorrhagic type.
About the Authors
O. I. Tsibirova
Hospital for Veterans of Wars
Russian Federation
Russian Federation
Tsibirova Olga I., head of Dept of Resuscitation and Intensive Care for Patients with Stroke
Saint Petersburg
M. A. Privalova
Hospital for Veterans of Wars; North-Western State Medical University n. a. I. I. Mechnikov
Russian Federation
Russian Federation
Privalova Maria Andreevna, PhD Med, head of Dept for Patients with Acute Cerebrovascular Accident, associate professor at Dept of Neurology n. a. academician S. N. Davidenkov
Saint Petersburg
M. G. Sokolova
North-Western State Medical University n. a. I. I. Mechnikov; Institute for Physiology n. a. I. P. Pavlov; Almazov National Medical Research Centre
Russian Federation
Russian Federation
Sokolova Maria G., DM Sci, associate professor, associate professor at Dept of Neurology n. a. academician S. N. Davidenkov, professor at Dept of Anatomy and Physiology of Humans and Animals, professor at Dept of Neurosurgery
Saint Petersburg
A. Yu. Ulitin
North-Western State Medical University n. a. I. I. Mechnikov; Almazov National Medical Research Centre
Russian Federation
Russian Federation
Ulitin Alexey Yu., DM Sci, professor, professor at Dept of Neurosurgery, head of Dept of Neurosurgery
Saint Petersburg
S. А. Privalova
Institute for Physiology n. a. I. P. Pavlov
Russian Federation
Russian Federation
Privalova Sofya A., postgraduate student
Saint Petersburg
A. A. Tsibirov
All-Russian Centre for Emergency and Radiation Medicine n. a. A. M. Nikiforov
Russian Federation
Russian Federation
Tsibirov Andrey A., neurosurgeon
Saint Petersburg
M. Ya. Belikova
Hospital for Veterans of Wars; St. Petersburg Bekhterev Psychoneurological Research Institute
Russian Federation
Russian Federation
Belikova Maria Ya., DM Sci, head of Dept of Computed Tomography, professor at Dept of Educational and Methodological Work
Saint Petersburg
References
1. Maksimova M. Yu. Clinical efficacy and antioxidant activity of Mildronate Russian Journal of Cardiology. 2009. No. 4 (78). Pp. 55–63.
2. Statsenko M. E., Turkina S. V., Lopushkova Yu. E. New data on a well-known drug: Focus on meldonium. Medical Counsil. 2021. No. 14. Pp. 44–51.
3. Sokolova M. G., Privalova M. A., et al. Clinical and laboratory rationale for the use of metabolic correctors for the treatment of patients with a new coronavirus infection COVID-19 in the acute period against the background of cerebrovascular disease. Medical Alphabet. Neurology and Psychiatry. 2022. No. 10 (2). Pp. 12–18. DOI: 10.33667/2078–5631–2022–10–12–16.
4. Fedin A. I., Solovyova E. Yu., Baranova O. A. Chronic cerebral ischemia and ischemic heart disease. Nervous Diseases. 2020. No. 3. Pp. 15–25.
5. Kheilo Yu.A., Danilogorskaya Yu.A., Nazarenko G. B. Indicators of bulbar capillaroscopy in CCI and ischemic heart disease. Therapy. 2020. No. 3 (37). Pp. 58–63.
6. Shiralieva R. K., Gasanov R. L. Use of Mildronate in patients with cognitive disorders due to cerebral stroke. Clinical medicine. 2007. No. 7, vol. 12/1. Pp. 71–73.
7. Adams HP, Kassell NF, Wisoff HS, Drake CG (1979) Intracranial saccular aneurysm and Moyamoya disease. Stroke 10: 174–179. [Aoki N (1993) Cerebrovascular bypass surgery for the treatment of Moyamoya disease: unsatisfactory outcome in the patients presenting with intracranial hemorrhage. Surg Neurol 40: 372–377].
8. Ando T, Iwai T, Shimizu K, Miwa Y, Deguchi K, Sakai N, Yamada H, Ohkuma A, Hunakoshi T (1988). Moyamoya disease associated with aneurysm. Analysis of six cases. Surg Cerebr Stroke 16: 161–167 (Jpn).
9. Aoki N (1993) Cerebrovascular bypass surgery for the treatment of moyamoya disease: Unsatisfactory outcome in the patients presenting with intracranial hemorrhage. Surg Neurol 40: 372–377.
10. Bucciero A, Carangelo B, Vizioli L. Giant basilar artery aneurysm associated with moyamoya disease. Case report and review of the literature. Acta Neurol (Napoli). 1994 Jun; 16 (3): 121–8. PMID: 7992661.
11. Canavero I, Vetrano IG, Zedde M, Pascarella R, Gatti L, Acerbi F, Nava S, Ferroli P, Parati EA, Bersano A. Clinical Management of Moyamoya Patients. J Clin Med. 2021 Aug 17; 10 (16): 3628. DOI: 10.3390/jcm10163628. PMID: 34441923; PMCID: PMC 8397113.
12. Graf J, Schwitalla JC, Albrecht P, Veltkamp R, Berlit P, Hartung HP, Aktas O, Kraemer M. Misdiagnoses and delay of diagnoses in Moyamoya angiopathy-a large Caucasian case series. J Neurol. 2019 May; 266 (5): 1153–1159. DOI: 10.1007/s00415–019–09245–9. Epub 2019 Feb 25. PMID: 30805794.
13. Kamada K, Imanishi M, Kawaguchi S, Koshimae N, Tokunaga H, Park YS (1993) Orbitozygomatic temporopolar approach for basilar aneurysm associated with moyamoya disease. Surg Cereb Stroke 21: 161–166 (Jpn).
14. Kawaguchi S, Sakaki T, Morimoto T, Kakizaki T, Kamada K. Characteristics of intracranial aneurysms associated with moya-moya disease. A review of 111 cases. Acta Neurochir (Wien). 1996; 138 (11): 1287–94. DOI: 10.1007/BF01411057. PMID: 8980731.
15. Kudo T., Takayama R., Mikawakuchi W. et al. Occlusion of internal carotid artery. Brain Nerve (Tokyo), 1957. No. 9. P. 757.
16. Kudo T. Spontaneous occlusion of the circle of Willis: A disease apparently confined to Japanese. Neurology, 1968. No. 18. P. 485–496.
17. Mikami T, Suzuki H, Komatsu K, Mikuni N. Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease. Neurol Med Chir (Tokyo). 2019 Oct 15; 59 (10): 361–370. DOI: 10.2176/nmc.ra.2019–0059. Epub 2019 Jul 6. PMID: 31281171; PMCID: PMC 6796064.
18. Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, Takenaka K, Ikeda H, Houkin K, Takagi Y, Kikuta K, Nozaki K, Hashimoto N, Koizumi A. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology. 2008 Jun 10; 70 (24 Pt 2): 2357–63. DOI: 10.1212/01.wnl.0000291012.49986.f9. Epub 2008 May 7. PMID: 18463369.
19. Nishimoto A., Takeuchi T. Abnormal cerebrovascular network related to the internal carotid arteries. J. Neurosurg. 1968. No. 29. P. 255–260.
20. Takeuchi K., Shimuzu K. Hypoplasia of the bilateral internal carotid arteries. Brain Nerve (Tokyo), 1957. No. 9. P. 37–43.
21. Yabumoto M, Funahashi K, Fujii T, Hayashi S, Komai N (1983) Moyamoya disease associated with intracranial aneurysms. Surg Neurol 20: 20–24.
22. Zhang H, Zheng L, Feng L. Epidemiology, diagnosis and treatment of moyamoya disease. Exp Ther Med. 2019 Mar; 17(3):1977–1984. doi: 10.3892/etm.2019.7198. Epub 2019 Jan 25. PMID: 30867689; PMCID: PMC 6395994.
Review
For citations:
Tsibirova O.I., Privalova M.A., Sokolova M.G., Ulitin A.Yu., Privalova S.А., Tsibirov A.A., Belikova M.Ya. Clinical observation of patient with moya-moya syndrome complicated by transient ischemic attack followed by development of hemorrhagic stroke. Features of diagnosis and treatment. Medical alphabet. 2023;(21):54-60. (In Russ.) https://doi.org/10.33667/2078-5631-2023-21-54-60
Views:
379
Email this article 